NOVITIUM PHARMA FDA Approval ANDA 211910

ANDA 211910

NOVITIUM PHARMA

FDA Drug Application

Application #211910

Application Sponsors

ANDA 211910NOVITIUM PHARMA

Marketing Status

Prescription001

Application Products

001SUSPENSION;ORAL25MG/ML0NAPROXENNAPROXEN

FDA Submissions

UNKNOWN; ORIG1AP2021-03-10STANDARD

Submissions Property Types

ORIG1Null7

TE Codes

001PrescriptionAB

CDER Filings

NOVITIUM PHARMA
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 211910
            [companyName] => NOVITIUM PHARMA
            [docInserts] => ["",""]
            [products] => [{"drugName":"NAPROXEN","activeIngredients":"NAPROXEN","strength":"25MG\/ML","dosageForm":"SUSPENSION;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"03\/10\/2021","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2021-03-10
        )

)

© 2021 FDA.report
This site is not affiliated with or endorsed by the FDA.